General

All Articles in the Category ‘General’

Leader in Pediatric Oncology Receives National Honor from American Cancer Society

Dr. Abby R. Rosenberg, director of the Palliative Care and Resilience lab at the Seattle Children’s Research Institute

Dr. Abby R. Rosenberg, director of the Palliative Care and Resilience (PCAR) lab at the Seattle Children’s Research Institute (SCRI); an associate professor of pediatric hematology/oncology at the University of Washington (UW); director of pediatrics at the UW Cambia Palliative Care Center of Excellence; and director of survivorship and outcomes research in pediatric oncology at the UW, has been awarded the 2021 Trish Greene Quality of Life Award by the American Cancer Society (ACS).

The prestigious award was presented to Dr. Rosenberg in an intimate ceremony in Seattle Children’s new Forest B building and honors those who have dedicated their career to research that improves the quality of life for cancer patients and their families.

Read full post »

Vaccines Are Now Available for Kids Under 5

On June 21, Seattle Children’s became one of the first locations in the country to offer COVID-19 vaccinations to children ages 6 months to 4 years old.

This was a day that Seattle Children’s staff has long worked toward, as Seattle Children’s doctors were also involved clinical trial research for COVID-19 vaccines for this age group. For children in the 6 months – 4-year-old age group, our COVID-19 vaccine clinical trial spots were highly sought after, with thousands of applicants for approximately 100 slots at Seattle Children’s.

Read full post »

Blessing the Seattle Children’s Story Pole

On June 1, 2022, Seattle Children’s opened the doors to our new Forest B building – the latest addition to the Seattle Children’s hospital campus.

When Seattle Children’s began planning for the Forest B building 10 years ago, we wanted to formally recognize that the hospital is located on the traditional land of the Coast Salish people through an art installation in the lobby. We sought out an artist with a deep understanding of the Pacific Northwest and a whimsical style that patients and families could connect with. We were lucky to find Shaun “Qwalsius” Peterson, who has been creating public art inspired by the Puyallup people’s heritage and the greater Pacific Northwest region for more than 20 years. Qwalsius designed, carved and erected a Story Pole in the Forest B lobby that will now be enjoyed by all the patients, families and workforce members who walk through our doors for decades to come. Read full post »

Meet the Seattle Children’s Nurse Who Helped Deliver More Than One Thousand Pounds of Medical Supplies to Ukraine

Jenna Engelsvold helped gather and personally deliver 23 suitcases full of medical supplies to the border of Ukraine in March.

“Helping other people is a really important part of my life.”

When Jenna Engelsvold first arrived at Seattle Children’s as a nursing student more than a decade ago, she knew this is where she wanted to be.

“I was walking down the hall and looking around and just felt this gut feeling that this was where I wanted to start my career. To this day, I have never regretted that decision,” she explained.

As Engelsvold’s passion for pediatrics grew while at Seattle Children’s, so did her career, starting as a nurse in 2011 and then joining the nurse practitioner team in 2018 after completing graduate school. In her current role, she cares for patients who have undergone cardiac surgery and helps enable parents to take care of their child once they leave the hospital.

Read full post »

Seattle Children’s Opens New “Forest B” Building

New “Forest B” Building Features More In-Patient and Operating Rooms, Cancer and Blood Disorders Care Facilities and more

On June 1st, Seattle Children’s opens the latest addition to the hospital campus — a building called “Forest B.”  Forest B is a project over 10 years in the making and will add an additional 310,000 square feet of space to the hospital campus.  

“Forest B is a critical addition to Seattle Children’s, given our region’s incredible historic and anticipated growth,” said Mandy Hansen, senior director of planning, design, and construction at Seattle Children’s. “The building gives our care teams the space they need to provide lifesaving and life-changing treatments, surgeries and procedures to even more patients in the coming years. The thoughtful design will also help us integrate more of our breakthrough research into the clinical care environment as we tirelessly work toward cures.”  Read full post »

“Spine at Risk” Safety Program Receives Prestigious Award from POSNA

Seattle Children’s Dr. Jennifer Bauer received prestigious award from POSNA for “Spine at Risk” Safety Program

Competition is steep to receive a research grant from the Pediatric Orthopedic Society of North America (POSNA), including the once-a-year awarded Quality, Safety, and Value Initiative (QSVI) Grant. This grant encourages the creation and implementation of quality and patient safety programming, and applicants must go through a rigorous multiple-tiered review process for the reward.

Seattle Children’s is thrilled that this year’s 2022 QSVI Grant Winner is Dr. Jennifer Bauer, Chief of Spine Surgery at Seattle Children’s hospital. Bauer was award this grant for her innovative work on the Spine at Risk Safety Program, which was done in partnership with co-investigators and Seattle Children’s spine partners Drs. Burt Yaszay, Wally Krengel and Klane White.

The Spine at Risk Program is a unique Seattle Children’s safety program run by a team of orthopedic and neurosurgery spine providers that ensures that all patients undergoing anesthesia will have appropriate precautions taken to make sure their spine and spinal cord remain safe while asleep. The program has helped protect our patients behind the scenes for over ten years at Seattle Children’s.

With this additional funding, Bauer and her team will continue to progress on previously published and internationally recognized research on the Spine at Risk Safety Program to improve its efficiency and enable it to be implemented at any pediatric hospital around the country.

What Parents Should Know About the Current Baby Formula Shortage

A confluence of factors has led to a nationwide baby formula shortage. Dr. Dale Lee, medical director of clinical nutrition at Seattle Children’s, shared some advice for parents with The Seattle Times.

Here are some key takeaways from Lee:

Read full post »

Legislative Wins for Child and Youth Behavioral Health in Washington State

The 2022 Washington State Legislative session concluded in mid-March, after a whirlwind 60-day session. This was a historic session for many reasons, especially for child and youth behavioral health.  There has been a growing focus on the national youth mental health crisis over the past year, and we are thrilled at the investment and commitment demonstrated in the legislature.  Read full post »

HHS Secretary Admiral Levine Visits Seattle Children’s to Discuss Youth Mental Health Crisis

Admiral Rachel L. Levine, MD, U.S. Assistant Secretary for Health, made a rare visit to Seattle Children’s on Tuesday. Her visit included a tour of the Psychiatry and Behavioral Medicine Unit (PBMU), Emergency Department and the Seattle Children’s Gender Clinic.   Read full post »

Seattle Children’s Therapeutics Announces Expansive Collaboration with Cellevolve to Advance Research for Childhood Brain Cancers

Seattle Children’s Therapeutics, a venture at Seattle Children’s, bringing cutting edge, curative technologies and therapies to defeat pediatric cancer and other diseases that impact children, today announced a collaboration with Cellevolve Bio, a development and commercialization company focused on cell therapies, aimed at developing and commercializing a suite of novel multiplex chimeric antigen receptors (CARs) for the treatment of pediatric central nervous system (CNS) malignancies.

Under the exclusive agreement, Seattle Children’s Therapeutics will conduct early-stage and pre-clinical discovery, and Phase 1 clinical trial development. Cellevolve will lead Phase 2 and subsequent clinical development with key Seattle Children’s Therapeutics involvement. Read full post »